Fleet Phospho Soda Recall

Fleet Phospho Soda Recall Lawyer
Medical research suggests that the incident rate of kidney failure associated with the use of oral sodium phosphates, such as Phospho-Soda® is 1 in 1000. The kidney damage caused by Phospho-soda is often called Acute Phosphate Nephropathy, Acute Renal Failure, Chronic Renal Failure, or Acute Nephrocalcinosis. If you or a loved one have suffered kidney disease or kidney damage that developed after taking Fleet® Phospho-soda® as a bowel cleanser in preparation for a colonoscopy or surgery, you may be entitled to compensation for your injury. Call one of our Fleet® Phospho-soda® lawyers today. We want to help.

Fleet Phospho Soda Recall - Harrisburg Pennsylvania Attorney
Fleet Phospho Soda Recall Attorney Harrisburg Pennsylvania Product Liability Lawyers Our Harrisburg Pennsylvania Phospho Soda Recall lawyers are currently offering free case evaluations to people who suffer from kidney damage as a result of using Fleet Phospho-soda or the Fleet EZ-Prep Bowel Cleansing System. Harrisburg Phospho Soda Recall Attorney

Fleet Recalls Phospho-Soda® Products
CB Fleet has recalled its Phospho-soda® laxative that it has aggressively promoted since the early 1990s as a safe bowel cleanser for colonoscopy and medical procedure preparation. Phospho-soda® is an over the counter saline laxative consisting mostly of monobasic sodium phosphate monohydrate and dibasic sodium phosphate heptahydrate. It is often taken to prepare for colonoscopy.

Fleet Phospho Soda Warning
Bowel cleansing agents such as Fleet Phospho Soda can cause kidney injury.

Stronger Warnings for Bowel Cleansing Agents
FDA is announcing new safety measures for oral sodium phosphate (OSP) products used for bowel cleansing before colonoscopies and other procedures. These products are associated with acute phosphate nephropathy, a rare but serious type of kidney injury. The events have been reported with the prescription products Visicol and OsmoPrep, and also over-the-counter sodium phosphate products when they are used as bowel cleansers. FDA first warned about this problem in 2006, but cases of kidney injury continue to be reported. So FDA is requiring the manufacturer of Visicol and OsmoPrep to take several steps. First, a boxed warning about the risk of acute phosphate nephropathy will be added to the product label. The manufacturer will also conduct a new clinical trial to further study the risk of acute kidney injury with these products, provide a Medication Guide for patients, and implement a risk evaluation and mitigation strategy to ensure that the benefits of using these products outweigh their risks. FDA believes that oral sodium phosphate products should be available only by prescription when they are used for bowel cleansing. Because of this, CB Fleet Company has voluntarily recalled the company's oral sodium phosphate products sold over the counter, (Fleet Phospho-soda and Fleet EZ-PREP) and has advised healthcare professionals not to instruct patients to use these products for bowel cleansing. Unico Holdings, Inc. is also recalling its OTC oral sodium phosphate products ...